Chemomab Therapeutics Ltd. CMMB
NASDAQ
| 06/30/2025 | 06/30/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.34% | -11.34% | -25.96% | ||
| Total Receivables | -13.58% | -13.58% | 384.41% | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | -- | -- | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 5.71% | 5.71% | 84.21% | ||
| Total Current Assets | -11.38% | -11.38% | -25.33% | ||
|
|
|||||
| Total Current Assets | -11.38% | -11.38% | -25.33% | ||
| Net Property, Plant & Equipment | -56.69% | -56.69% | -7.05% | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -12.61% | -12.61% | -11.43% | ||
| Total Assets | -13.18% | -13.18% | -24.43% | ||
|
|
|||||
| Total Accounts Payable | -22.86% | -22.86% | -22.59% | ||
| Total Accrued Expenses | -36.01% | -36.01% | -33.44% | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -- | -- | -1.74% | ||
| Total Finance Division Other Current Liabilities | -- | -- | -- | ||
| Total Other Current Liabilities | -- | -- | -- | ||
| Total Current Liabilities | -36.36% | -36.36% | -30.17% | ||
|
|
|||||
| Total Current Liabilities | -36.36% | -36.36% | -30.17% | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -- | -- | -14.35% | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | -41.06% | -41.06% | -29.21% | ||
|
|
|||||
| Common Stock & APIC | 1.17% | 1.17% | 0.15% | ||
| Retained Earnings | -1.94% | -1.94% | -3.24% | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | -6.68% | -6.68% | -23.23% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | -6.68% | -6.68% | -23.23% | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -6.68% | -6.68% | -23.23% | ||
|
|
|||||